Jaundice in a Child with Sickle Cell Anemia: A Case Based Approach

Area of Science:

• Hematology
• Gastroenterology
• Pediatrics

Background:

• Sickle cell anemia (SCA) is an inherited blood disorder affecting the beta globin gene, leading to complications in the hepatobiliary system in 10-40% of patients.
• Jaundice in SCA patients can stem from multifactorial causes, including vaso-occlusive crisis (VOC)-induced sickle cell hepatopathy, cholelithiasis, viral hepatitis, and hemochromatosis.
• The clinical overlap and coexistence of various liver conditions in SCA patients present diagnostic challenges.

Discussion:

• This case highlights a child with SCA experiencing conjugated hyperbilirubinemia, biliary obstruction, and subsequent complications including post-sphincterotomy bleed, retroperitoneal hematoma, and sepsis with acute sickle hepatic crisis.
• Effective management involved ERCP, biliary stenting, and addressing complications, emphasizing the need for a stepwise approach in managing jaundice in SCA.
• Stressors triggering vaso-occlusive crisis (VOC) must be managed proactively with hydration, oxygen, maintaining adequate hemoglobin levels, and minimizing hemoglobin S fraction.

Key Insights:

• Sickle cell hepatopathy encompasses acute sickle hepatic crisis, acute hepatic sequestration, and sickle cell intrahepatic cholestasis, often exacerbated by VOC.
• Hemolysis in SCA leads to gallstones, increasing the risk of associated complications.
• Patients with SCA and conjugated hyperbilirubinemia are considered high-risk and necessitate a multidisciplinary team approach for optimal care.

Outlook:

• Future management should focus on early identification and intervention for hepatobiliary complications in SCA.
• Preventive strategies, including vaccinations and iron chelation therapy, are vital for long-term patient well-being.
• Continued research into the pathophysiology and treatment of sickle cell hepatopathy will improve patient outcomes.